Live Markets: A health boost for the STOXX

Genmab A/S

06/10/2026 08:54

Adds blog post
STOXX 600 up 0.8%
Healthcare stocks lead gains, boosted by 8% jump in Genmab shares
Wall St futures steady
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

     
A HEALTH BOOST FOR THE STOXX
Europe's STOXX 600 .STOXX is up 0.8%, getting a boost from healthcare names which are dominating the top ten biggest gainers in the index. 
They are being led higher by Denmark-based biotech company Genmab GMAB.CO, which has jumped over 8% to its highest in around three years. Genmab and US drugmaker AbbVie ABBV.N on Monday said their combination treatment for patients newly diagnosed with a type of lymphoma reduced the risk of disease progression or death in a late-stage study.
An index of European healthcare stocks .SXDP is up 1.%, on track for its biggest daily rise since mid-September.
The rise was enough to put it atop the biggest sectoral gainers, followed by media .SXMP and banks .SX7P, which rose 1.4% and 1.2% respectively. 
Oil and gas .SXEP was meanwhile the only sector to fall, down 0.2%, as Brent crude futures LCOc1 were a touch lower on the day just below the $100 mark. 
The DAX .GDAXI and FTSE .FTSE were also both up around 0.8%, while France's CAC .FCHI lagged somewhat, up 0.4%.

(Sophie Kiderlin)
*****

EARLIER ON LIVE MARKETS: 
EUROPE BEFORE THE BELL: READY FOR A JUMP CLICK HERE
SPAIN TO FRANCE: HOLD MY CERVEZA CLICK HERE